# FDA 483 - Sri Krishna Pharmaceuticals Limited Unit I - April 18, 2025

Source: https://www.keypedia.com/records/483/sri-krishna-pharmaceuticals-limited-unit-i/3a5ac51e-f6e9-4299-a0e6-d218b226bcab

> FDA 483 for Sri Krishna Pharmaceuticals Limited Unit I on April 18, 2025. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Sri Krishna Pharmaceuticals Limited Unit I
- Inspection Date: 2025-04-18
- Product Type: other
- Office Name: Division of Information Disclosure Policy
- Summary: The content of the FDA 483 document was not provided in the request. Therefore, a summary detailing the company name, inspection dates, main violations/issues, regulatory framework, and required actions cannot be generated as the source material is missing.

## Related Officers

- [Arsen Kanapetyan](https://www.keypedia.com/people/arsen-kanapetyan/e0df99e3-40b8-47fe-9d97-834473743965)
- [Clinton J. Iott](https://www.keypedia.com/people/clinton-j-iott/d6aa152d-f78c-4230-86bd-40e85319f008)

Company: https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-limited-unit-i/3f741624-c558-4b26-9700-dd78147a0522

Office: https://www.keypedia.com/offices/division-of-information-disclosure-policy/0c0ebf49-2470-4002-937b-bb098361ac5f